Literature DB >> 21120714

Armed-disarmed effects in carbohydrate chemistry: history, synthetic and mechanistic studies.

Bert Fraser-Reid1, J Cristóbal López.   

Abstract

This chapter begins with an account of the serendipitous events that led to the development of n-pentenyl glycosides (NPGs) as glycosyl donors, followed by the chance events that laid the foundation for the armed-disarmed strategy for oligosaccharide assembly. A key mechanistic issue for this strategy was that, although both armed and disarmed entities could function independently as glycosyl donors, when one was forced to compete with the other for one equivalent of a halonium ion, the disarmed partner was found to function as a glycosyl acceptor. The phenomenon was undoubtedly based on reactivity, but further insight came unexpectedly. Curiosity prompted an examination of how ω-alkenyl glycosides, other than n-pentenyl, would behave. Upon treatment with wet N-bromosuccinimide, allyl, butenyl, and hexenyl glucosides gave bromohydrins, whereas the pentenyl analog underwent oxidative hydrolysis to a hemiacetal. Although the answer was definitive, an in depth comparison of n-pentenyl and n-hexenyl glucosides was carried out which provided evidence in support of the transfer of cyclic bromonium ion between alkenes in a steady-state phenomenon. It was found that for two ω-alkenyl glycosides having a relative reactivity ratio of only 2.6:1, nondegenerate bromonium transfer enabled the faster reacting entity to be converted completely to product, while the slower reacting counterpart was recovered completely. This nuance suggests that in the armed/disarmed coupling, such a nondegenerate steady-state transfer is ultimately responsible for determining how the reactants are relegated to donor or acceptor roles.Development of chemoselective armed/disarmed coupling led to another phase in the sequence of serendipities. During experiments to glycosylate an acceptor diol, it was found that armed and disarmed donor's glycosylated different hydroxyl groups. This observation caused us to embark on studies of regioselective glycosylation. One of these studies showed that it is possible to activate selectively n-pentenyl orthoesters (NPOEs) over other n-pentenyl donors, and that this chemoselective process enables regioselective glycosylation. As a result, reaction partners can be so tuned that glycosylation of an acceptor with nine free hydroxyl groups by an n-pentenyl orthoester donor carrying two free hydroxyl groups is able to furnish a single product in 42% yield. Experiments such as the latter suggest that the donor favors a particular hydroxyl group, and/or that a particular hydroxyl favors the donor. Either option implies that the principle of reciprocal donor acceptor selectivity (RDAS) is in operation.Such examples of regioselective glycosylation provide an alternative to the traditional practice of multiple protection/deprotection events to ensure that the only free hydroxyl group among glycosyl partners is the one to be presented to the donor. By avoiding such protection/deprotections, there can be substantial savings of time and material - as well as nervous anxiety.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21120714     DOI: 10.1007/128_2010_105

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  16 in total

Review 1.  The Experimental Evidence in Support of Glycosylation Mechanisms at the SN1-SN2 Interface.

Authors:  Philip Ouma Adero; Harsha Amarasekara; Peng Wen; Luis Bohé; David Crich
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

2.  Influence of protecting groups on the anomeric equilibrium; case of the 4,6-O-benzylidene acetal in the mannopyranose series.

Authors:  Indrajeet Sharma; Luis Bohé; David Crich
Journal:  Carbohydr Res       Date:  2012-06-07       Impact factor: 2.104

3.  Dissecting the influence of oxazolidinones and cyclic carbonates in sialic acid chemistry.

Authors:  Pavan K Kancharla; Chandrasekhar Navuluri; David Crich
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-13       Impact factor: 15.336

4.  A simple strategy for glycosyltransferase-catalyzed aminosugar nucleotide synthesis.

Authors:  Jianjun Zhang; Shanteri Singh; Ryan R Hughes; Maoquan Zhou; Manjula Sunkara; Andrew J Morris; Jon S Thorson
Journal:  Chembiochem       Date:  2014-03-21       Impact factor: 3.164

5.  Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.

Authors:  Debashis Dhara; Scott M Baliban; Chang-Xin Huo; Zahra Rashidijahanabad; Khandra T Sears; Setare Tahmasebi Nick; Anup Kumar Misra; Sharon M Tennant; Xuefei Huang
Journal:  Chemistry       Date:  2020-10-22       Impact factor: 5.236

6.  Automated Solution-Phase Synthesis of S-Glycosides for the Production of Oligomannopyranoside Derivatives.

Authors:  Mallory K Kern; Nicola L B Pohl
Journal:  Org Lett       Date:  2020-05-20       Impact factor: 6.005

7.  Probing the influence of a 4,6-O-acetal on the reactivity of galactopyranosyl donors: verification of the disarming influence of the trans-gauche conformation of C5-C6 bonds.

Authors:  Myriame Moumé-Pymbock; Takayuki Furukawa; Sujit Mondal; David Crich
Journal:  J Am Chem Soc       Date:  2013-09-11       Impact factor: 15.419

Review 8.  A propos of glycosyl cations and the mechanism of chemical glycosylation; the current state of the art.

Authors:  Luis Bohé; David Crich
Journal:  Carbohydr Res       Date:  2014-07-01       Impact factor: 2.104

9.  A 3,4-trans-fused cyclic protecting group facilitates α-selective catalytic synthesis of 2-deoxyglycosides.

Authors:  Edward I Balmond; David Benito-Alifonso; Diane M Coe; Roger W Alder; Eoghan M McGarrigle; M Carmen Galan
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-20       Impact factor: 15.336

10.  Convergent synthesis of the tetrasaccharide repeating unit of the cell wall lipopolysaccharide of Escherichia coli O40.

Authors:  Abhijit Sau; Anup Kumar Misra
Journal:  Beilstein J Org Chem       Date:  2012-11-22       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.